{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:55:12Z","timestamp":1791280512298,"version":"4.1.0"},"reference-count":46,"publisher":"The Company of Biologists","issue":"3-4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Endometrial cancer \u2013 the most common malignancy of the female reproductive tract \u2013 arises from the specialized epithelial cells that line the inner surface of the uterus. Although significant advances have been made in our understanding of this disease in recent years, one significant limitation has been the lack of a diverse genetic toolkit for the generation of mouse models. We identified a novel endometrial-specific gene, Sprr2f, and developed a Sprr2f-Cre transgene for conditional gene targeting within endometrial epithelium. We then used this tool to generate a completely penetrant Lkb1 (also known as Stk11)-based mouse model of invasive endometrial cancer. Strikingly, female mice with homozygous endometrial Lkb1 inactivation did not harbor discrete endometrial neoplasms, but instead underwent diffuse malignant transformation of their entire endometrium with rapid extrauterine spread and death, suggesting that Lkb1 inactivation was sufficient to promote the development of invasive endometrial cancer. Mice with heterozygous endometrial Lkb1 inactivation only rarely developed tumors, which were focal and arose with much longer latency, arguing against the idea \u2013 suggested by some prior studies \u2013 that Lkb1 is a haploinsufficient tumor suppressor. Lastly, the finding that endometrial cancer cell lines were especially sensitive to the mTOR (mammalian target of rapamycin) inhibitor rapamycin prompted us to test its efficacy against Lkb1-driven endometrial cancers. Rapamycin monotherapy not only greatly slowed disease progression, but also led to striking regression of pre-existing tumors. These studies demonstrate that Lkb1 is a uniquely potent endometrial tumor suppressor, but also suggest that the clinical responses of some types of invasive cancers to mTOR inhibitors may be linked to Lkb1 status.<\/jats:p>","DOI":"10.1242\/dmm.004440","type":"journal-article","created":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T01:34:22Z","timestamp":1265679262000},"page":"181-193","source":"Crossref","is-referenced-by-count":108,"title":["<i>Lkb1<\/i>inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy"],"prefix":"10.1242","volume":"3","author":[{"given":"Cristina M.","family":"Contreras","sequence":"first","affiliation":[{"name":"Department of Pathology"},{"name":"Simmons Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra A.","family":"Akbay","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Simmons Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa D.","family":"Gallardo","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Simmons Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Marshall","family":"Haynie","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Simmons Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenath","family":"Sharma","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Tagao","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, UT Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Bardeesy","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, UT Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Settleman","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Kin","family":"Wong","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego H.","family":"Castrillon","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Simmons Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","reference":[{"key":"2021042500104951200_b1-0030181","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2353\/ajpath.2008.071179","article-title":"Differential roles of telomere attrition in type I and II endometrial carcinogenesis","volume":"173","author":"Akbay","year":"2008","journal-title":"Am J Pathol"},{"key":"2021042500104951200_b2-0030181","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","article-title":"Lkb1-dependent signaling pathways","volume":"75","author":"Alessi","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"2021042500104951200_b3-0030181","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1093\/nar\/gkg517","article-title":"Dragon ERE Finder version 2, A tool for accurate detection and analysis of estrogen response elements in vertebrate genomes","volume":"31","author":"Bajic","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2021042500104951200_b4-0030181","volume-title":"Corpus: Epithelial Tumors (in Principles and Practice of Gynecologic Oncology)","author":"Barakat","year":"2000"},{"key":"2021042500104951200_b5-0030181","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"2021042500104951200_b6-0030181","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/0008-5472.CAN-07-5014","article-title":"Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas","volume":"68","author":"Contreras","year":"2008","journal-title":"Cancer Res"},{"key":"2021042500104951200_b7-0030181","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/0008-5472.CAN-07-5014","article-title":"Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas","volume":"68","author":"Contreras","year":"2008","journal-title":"Cancer Res"},{"key":"2021042500104951200_b8-0030181","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","article-title":"Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice","volume":"68","author":"Daikoku","year":"2008","journal-title":"Cancer Res"},{"key":"2021042500104951200_b9-0030181","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccr.2004.05.029","article-title":"Focus on endometrial and cervical cancer","volume":"5","author":"Ellenson","year":"2004","journal-title":"Cancer Cell"},{"key":"2021042500104951200_b10-0030181","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrc2192","article-title":"Maximizing mouse cancer models","volume":"7","author":"Frese","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2021042500104951200_b11-0030181","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/dvg.20310","article-title":"Generation of a germ cell-specific mouse transgenic Cre line, Vasa-Cre","volume":"45","author":"Gallardo","year":"2007","journal-title":"Genesis"},{"key":"2021042500104951200_b12-0030181","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1534\/genetics.107.074823","article-title":"Genomewide discovery and classification of candidate ovarian fertility genes in the mouse","volume":"177","author":"Gallardo","year":"2007","journal-title":"Genetics"},{"key":"2021042500104951200_b13-0030181","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/GCO.0b013e328235a5c6","article-title":"Endometrial stem cells","volume":"19","author":"Gargett","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2021042500104951200_b14-0030181","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0092-8674(93)90644-6","article-title":"Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting","volume":"73","author":"Gu","year":"1993","journal-title":"Cell"},{"key":"2021042500104951200_b15-0030181","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/0008-5472.CAN-07-3225","article-title":"LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis","volume":"68","author":"Gurumurthy","year":"2008","journal-title":"Cancer Res"},{"key":"2021042500104951200_b16-0030181","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1038\/onc.2008.342","article-title":"LKB1; linking cell structure and tumor suppression","volume":"27","author":"Hezel","year":"2008","journal-title":"Oncogene"},{"key":"2021042500104951200_b17-0030181","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1128\/MCB.01621-07","article-title":"Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms","volume":"28","author":"Hezel","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2021042500104951200_b18-0030181","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1016-8478(23)13069-X","article-title":"Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus","volume":"17","author":"Hong","year":"2004","journal-title":"Mol Cells"},{"key":"2021042500104951200_b19-0030181","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2021042500104951200_b20-0030181","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/onc.2008.363","article-title":"beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus","volume":"28","author":"Jeong","year":"2009","journal-title":"Oncogene"},{"key":"2021042500104951200_b21-0030181","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06030","article-title":"LKB1 modulates lung cancer differentiation and metastasis","volume":"448","author":"Ji","year":"2007","journal-title":"Nature"},{"key":"2021042500104951200_b22-0030181","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/onc.2008.109","article-title":"BIBW2992, an irreversible EGFR\/HER2 inhibitor highly effective in preclinical lung cancer models","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"2021042500104951200_b23-0030181","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1158\/1078-0432.CCR-07-0321","article-title":"Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma","volume":"14","author":"Lu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2021042500104951200_b24-0030181","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1107\/S1744309106015168","article-title":"Crystallization of hepatocyte nuclear factor 1beta in complex with DNA","volume":"62","author":"Lu","year":"2006","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"2021042500104951200_b25-0030181","doi-asserted-by":"crossref","first-page":"19936","DOI":"10.1073\/pnas.0707498104","article-title":"Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling","volume":"104","author":"McDermott","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042500104951200_b26-0030181","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0076-6879(07)38023-3","article-title":"High-throughput lung cancer cell line screening for genotype-correlated sensitivity to an EGFR kinase inhibitor","volume":"438","author":"McDermott","year":"2008","journal-title":"Methods Enzymol"},{"key":"2021042500104951200_b27-0030181","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","article-title":"Targeting the mTOR signaling network for cancer therapy","volume":"27","author":"Meric-Bernstam","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021042500104951200_b28-0030181","doi-asserted-by":"crossref","first-page":"247 e1","DOI":"10.1016\/j.ajog.2006.10.872","article-title":"Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model","volume":"196","author":"Milam","year":"2007","journal-title":"Am. J. Obstet. Gynecol"},{"key":"2021042500104951200_b29-0030181","volume-title":"Manipulating the Mouse Embryo: A Laboratory Manual","author":"Nagy","year":"2003"},{"key":"2021042500104951200_b30-0030181","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","article-title":"Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR","volume":"98","author":"Neshat","year":"2001","journal-title":"PNAS"},{"key":"2021042500104951200_b31-0030181","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.1158\/0008-5472.CAN-05-2620","article-title":"High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma","volume":"65","author":"Oda","year":"2005","journal-title":"Cancer Res"},{"key":"2021042500104951200_b32-0030181","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1200\/jco.2006.24.18_suppl.3003","article-title":"Molecular correlates associated with a phase II study of temsirolimus (CCI-779) in patients with metastatic or recurrent endometrial cancer-NCIC IND 160","volume":"24","author":"Oza","year":"2006","journal-title":"J. Clin. Oncol. (Meeting Abstracts)"},{"key":"2021042500104951200_b33-0030181","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00335-002-2205-4","article-title":"Mouse Sprr locus: a tandem array of coordinately regulated genes","volume":"14","author":"Patel","year":"2003","journal-title":"Mamm Genome"},{"key":"2021042500104951200_b34-0030181","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1158\/0008-5472.CAN-07-5169","article-title":"Lkb1 deficiency causes prostate neoplasia in the mouse","volume":"68","author":"Pearson","year":"2008","journal-title":"Cancer Res"},{"key":"2021042500104951200_b35-0030181","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2021042500104951200_b36-0030181","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.1073\/pnas.0900465106","article-title":"mTOR and HIF-1{alpha}-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome","volume":"106","author":"Shackelford","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042500104951200_b37-0030181","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/geno.1998.5607","article-title":"Mouse Sprr2 genes: a clustered family of genes showing differential expression in epithelial tissues","volume":"55","author":"Song","year":"1999","journal-title":"Genomics"},{"key":"2021042500104951200_b38-0030181","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat Genet"},{"key":"2021042500104951200_b39-0030181","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/07357900802427919","article-title":"Somatic alterations of the serine\/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma","volume":"27","author":"Strazisar","year":"2009","journal-title":"Cancer Invest"},{"key":"2021042500104951200_b40-0030181","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/cncr.22465","article-title":"Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called \u2018low-risk\u2019 patients with well and moderately differentiated tumors","volume":"109","author":"Susini","year":"2007","journal-title":"Cancer"},{"key":"2021042500104951200_b41-0030181","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/rep.0.1260171","article-title":"Global gene profiling analysis of mouse uterus during the oestrous cycle","volume":"126","author":"Tan","year":"2003","journal-title":"Reproduction"},{"key":"2021042500104951200_b42-0030181","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1051\/rnd:2006037","article-title":"Gene expression pattern and hormonal regulation of small proline-rich protein 2 family members in the female mouse reproductive system during the estrous cycle and pregnancy","volume":"46","author":"Tan","year":"2006","journal-title":"Reprod Nutr Dev"},{"key":"2021042500104951200_b43-0030181","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res"},{"key":"2021042500104951200_b44-0030181","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1078-0432.CCR-07-4007","article-title":"Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling","volume":"14","author":"Wei","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2021042500104951200_b45-0030181","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2008.11.036","article-title":"Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model","volume":"277","author":"Wei","year":"2009","journal-title":"Cancer Lett"},{"key":"2021042500104951200_b46-0030181","doi-asserted-by":"crossref","first-page":"e5137","DOI":"10.1371\/journal.pone.0005137","article-title":"Somatic LKB1 mutations promote cervical cancer progression","volume":"4","author":"Wingo","year":"2009","journal-title":"PLoS ONE"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/3\/3-4\/181\/1617927\/181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/3\/3-4\/181\/1617927\/181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T20:59:00Z","timestamp":1711227540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/3\/3-4\/181\/2356\/Lkb1-inactivation-is-sufficient-to-drive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,8]]},"references-count":46,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2010,3,8]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.004440","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,8]]}}}